News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|April 21, 2017

Trustworthy Information on Ovarian Cancer

Advertisement

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
ovarian cancer

Understanding Your Stage 2 Ovarian Cancer

ByRyan Scott
October 21st 2025
Image of ovaries.

Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer

ByKyle Doherty
October 19th 2025
ovarian cancer

Keytruda Combo Improves Progression, Survival in Recurrent Ovarian Cancer

ByTim Cortese
October 18th 2025
Image of ovaries.

FDA Grants Breakthrough Status to Raludotatug Deruxtecan in Ovarian Cancer

BySpencer Feldman
September 15th 2025
Image of ovary.

FDA Accepts New Drug Application for Relacorilant in Ovarian Cancer

ByAlex Biese
September 11th 2025
Advertisement
Advertisement

Trending on CURE

1

Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer

2

Trodelvy Plus Keytruda Upholds Quality of Life in TNBC

3

Stem Cell Transplant: Why This Treatment Is Still a ‘Standard Regimen’ for Blood Cancer

4

ADC Use Rapidly Growing in Metastatic Breast Cancer Treatment

5

Stage 1 Multiple Myeloma Treatment Options and Side Effect Management

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.